{"abstract": "Samuel D. Waksal, the biotechnology executive whose insider trading landed him and his friend Martha Stewart in prison, is trying to make a comeback. His new company, Kadmon Pharmaceuticals, said it had acquired Three Rivers Pharmaceuticals, a privately held company in that mainly sells drugs to treat hepatitis C.", "web_url": "https://dealbook.nytimes.com/2010/10/26/former-imclone-chief-acquires-drug-company/", "snippet": "Samuel D. Waksal, the biotechnology executive whose insider trading landed him and his friend Martha Stewart in prison, is trying to make a comeback. His new company, Kadmon Pharmaceuticals, said it had acquired Three Rivers Pharmaceuticals, a pri...", "lead_paragraph": "Samuel D. Waksal, the biotechnology executive whose insider trading landed him and his friend Martha Stewart in prison, is trying to make a comeback.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Former Chief of ImClone Buys a Drug Company", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [], "pub_date": "2010-10-26T06:30:47+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "", "_id": "nyt://article/ee35611f-b75f-5a3d-b8af-892f1b031058", "word_count": 144, "uri": "nyt://article/ee35611f-b75f-5a3d-b8af-892f1b031058"}